JPRN-UMIN000006759
Recruiting
Phase 2
Phase II Study of neoadjuvant chemotherapy with carboplatin,pemetrexed and bevacizumab in patients with non-squemous non-small-cell lung cancer - Phase II Study of neoadjuvant chemotherapy with carboplatin,pemetrexed and bevacizumab in patients with non-squemous non-small-cell lung cancer
niversity of Tsukuba, Faculty of Medicine, Department of Thoracic Surgery0 sites30 target enrollmentNovember 24, 2011
Conditionson-squamous,non-small-cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on-squamous,non-small-cell lung cancer
- Sponsor
- niversity of Tsukuba, Faculty of Medicine, Department of Thoracic Surgery
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Uncontrolled infection or Serious medical complications 2\)Uncontrollable diabetes mellitus 3\)Uncontrollable hypertension 4\)Therapeutic anticoagulopathy (except Aspirin within 325mg/day) 5\)Current or previous history of hemoptysis 6\)Evidence of bleeding diathesis or hemoptysis 7\)With great vessel invasion 8\)Cavity in tumor 9\)Uncontrollable gastrointestinal ulceration 10\)Current or previous(within the last 1 year) history of GI perforration 11\)History of severe heart disease 12\)Interstitial pneumonia or pulmonary fibrosis detectableon chest X\-ray 13\)Multiple primary cancer 14\)With a history of drug sensitivity 15\)Patients who do not want to take vitamin preparation 16\)Serious psychiatric illness or psychological symptom 17\)Women who are pregnant, lactating or with childbearing potential 18\)Ineligible based on decision of an investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Phase II study of neo-adjuvant chemotherapy with combination therapy of gemcitabine and S-1 in patients with resectable pancreatic cancerresectable pancreatic cancerJPRN-UMIN000005912Tokai university, school of medicine50
Completed
Phase 2
Phase II study of neoadjuvant chemotherapy with CPT-11 and S-1 for locally advanced colorectal cancer with lymph node metastases.locally advanced colorectal cancer with lymph node metastasesJPRN-UMIN000001698iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35
Completed
Not Applicable
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
Completed
Not Applicable
Feasibility study of adjuvant chemotherapy with carboplatin and nab-paclitaxel for resected NSCLCresected NSCLC(stage II - IIIB)JPRN-UMIN000011910Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine21
Recruiting
Phase 2
Phase II study of the neoadjuvant chemotherapy of GEM/nab-PTX for biological borderline-resectable pancreatic cancerpancreatic cancerC535836JPRN-jRCT1041230068Ebata Tomoki50